✦ LIBER ✦

Predictors of complete responses with denileukin diftitox in cutaneous T-cell lymphoma

✍ Scribed by Francine Foss; Madeleine Duvic; Elise A. Olsen

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 659 KB
Volume: 86
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.22039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lethal vascular leak syndrome after deni

Lethal vascular leak syndrome after denileukin diftitox administration to a patient with cutaneous gamma/delta T-cell lymphoma and occult cirrhosis

✍ Andrew B. Avarbock; Alison W. Loren; Jason Y. Park; Jacqueline M. Junkins-Hopkin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

De novo maintenance therapy with denileu

De novo maintenance therapy with denileukin diftitox (Ontak®) in a patient with peripheral T-cell lymphoma is associated with prolonged remission

✍ Bryan Y. Wong; Yupo Ma; Robert Fitzwilson; Nam H. Dang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 1021 KB

Multicenter study of pegylated liposomal

Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma

✍ Uwe Wollina; Reinhard Dummer; Norbert H. Brockmeyer; Helga Konrad; J.-O. Busch; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## Abstract ## BACKGROUND In single center studies and case reports, it was shown that pegylated liposomal doxorubicin (PEG‐DOXO) was effective as second‐line therapy for patients with cutaneous T‐cell lymphoma (CTCL). The objective of this study was to evaluate the efficacy and toxicity of single

Cutaneous T-cell lymphoma in a patient i

Cutaneous T-cell lymphoma in a patient infected with human immunodeficiency virus type 1: Use of radiation therapy

✍ Jeffrey Goldstein; Norwin Becker; John Delrowe; Lawrence Davis 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 888 KB

A patient with cutaneous T-cell lymphoma (CTCL) and acquired immune deficiency syndrome (AIDS) is presented. The patient had a localized lesion on his scalp. Evaluation for systemic lymphoma was negative. A biopsy specimen showed superficial and deep dermal infiltrates of pleomorphic lymphocytes. Im

Phase II trial of interferon-α-2a plus p

Phase II trial of interferon-α-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma

✍ Vanna Chiarion-Sileni; Antonio Bononi; Cleto Veller Fornasa; Mariella Soraru; Ma 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Purpose: To evaluate the efficacy and side effects of psolaren with ultraviolet light a (puva) and interferon-alpha-2a (ifn-alpha-2a) in patients with mycosis fungoides (mf) and sézary syndrome (ss). ## Patients and methods: From may 1993 to january 1999, 63 symptomatic patients with all stage

Normal serum neuron specific enolase (NS

Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy : An early predictor of complete response and survival in patients with small cell lung carcinoma

✍ Karim Fizazi; Isabelle Cojean; Jean-Pierre Pignon; Olivier Rixe; Michel Gatineau 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

BACKGROUND. Serum neuron specific enolase (NSE) is the most sensitive tumor